Digital Therapeutics (DTx)

NEW

2022/08/04

Technology of Japanese start-up featured by doctors (Series #21)

The Second Part: TechDoctor Moving Toward an Era Where Data Improves “Wellness”

TechDoctor announced in June of this year that it had raised 500 million Japanese yen in a Series A round. We will explain the company's technology, focusing on an interview with Kazushu Minato, CEO of TechDoctor, a fast-growing medical data analysis startup.

Dr. Shinpaku

NEW

2022/07/21

Technology of Japanese start-up featured by doctors (Series #20)

The First Part: TechDoctor Moving Toward an Era Where Data Improves “Wellness”

Digital biomarkers, which can acquire and analyze data that is difficult to obtain with conventional biomarkers, can contribute to shorter time to diagnosis and earlier treatment. The “SelfDoc.” wearable outpatient solution for psychiatry and the “SelfBase” medical data analysis platform developed by TechDoctor, Inc. which is involved in the development of digital biomarkers will be explained.

Dr. Shinpaku

2022/06/30

Discussion on Digital Health

Online Roundtable Discussion Among Clinical Doctors 【Part 3】

This is the third and final part of the Online Roundtable Discussion Among Clinical Doctors on “About the Ongoing Application of Digital Technology in the Medical Field.” We will ask slightly different questions to doctors about their honest opinions about digital health.

LSMIP Editorial Office

2022/04/28

Discussion on Digital Health

Online Roundtable Discussion Among Clinical Doctors 【Part 2】

We are pleased to present the second part of the Online Roundtable Discussion Among Clinical Doctors, in which they share their views on the current state of digital health and what they expect in the future. This time, we asked questions about the content of the previous roundtable discussion. The following is a frank discussion by three clinical doctors on these questions.

LSMIP Editorial Office

2022/02/22

Discussion on Digital Health

Online Roundtable Discussion Among Clinical Doctors 【Part 1】

In recent years, digital transformation has been expected to advance in various fields, but how much digitalization is taking place in the medical field? How far has digitalization progressed in the medical field, and what are people in the medical field thinking about digital health? The topic of this meeting is “About the Ongoing Application of Digital Technology in the Medical Field.” The content of this roundtable will be divided into three parts.

LSMIP Editorial Office

2021/09/24

Psychiatry and the Potential of Digital Tools(Series #3)

Current Status of Digital Therapeutics for Mild Cognitive Impairment

The number of patients with Alzheimer's disease (AD) is increasing, and digital therapeutics (DTx) for AD treatment is the focus of much attention. In the U.S., there are some startups that are supported by colossal research funds for research on screening for mild cognitive impairment (MCI). Dr. Y will explain the future of MCI treatment and DTx from the perspective of an active psychiatrist.

Dr. Y

2021/08/06

Psychiatry and the Potential of Digital Tools(Series #2)

Digital Screening for Cognitive Impairment

With the FDA approval of Aducanumab for the treatment of Alzheimer's disease, how will it affect future treatments? Dr. Y, a psychiatrist, explains his views on this issue, including expectations for digital therapeutics to identify mild cognitive impairment (MCI).

Dr. Y

2021/06/21

Psychiatry and the Potential of Digital Tools (Series #1)

The Impact of Changes in the COVID19 Pandemic on Psychiatry

Expectations for digital tools
In this new series of columns, an psychiatrist in Japan talks about the potential of digital tools in psychiatry. In this first part of a series, we present the expectations for digital tools for psychiatry in the COVID-19 Pandemic.

Dr. Y

2021/05/11

Technology of Japanese start-up featured by doctors (Series #1)

CureApp SC, the first Nicotine Addiction Therapeutics App receives regulatory approval in Japan

Nicotine Addiction treatment realizes telemedicine and digital healt

Dr. Shinpaku, an internist specializing in respiratory medicine and infectious diseases, writes a new series of columns featuring innovative technologies from Japanese startups. In the first of the series, he focuses on CureApp's Nicotine Addiction Therapeutics App.

Dr. Shinpaku

Digital Health
U.S. eHealth Journal

Vol. 70 (Issued at 2022/08/09)

ジャーナル70号のトピックは、デジタルセラピューティクス DTx の Sidekick (乳癌)、Twill (多発性硬化症)、Swing Therapeutics (線維筋痛症)。JMIR論文(デジタルヘルス開発の臨床的堅牢性) 、など

Most Popular

1

Online Roundtable Discussion Among Clinical Doctors 【Part 3】

LSMIP Editorial Office

2

LSMIP Editorial Office

3

The First Part: TechDoctor Moving Toward an Era Where Data Improves “Wellness”

Dr. Shinpaku

4

The second part: How Should We View ‘Teledentistry’?

Megumi Kamo DDS, PhD.

5

The Second Part: TechDoctor Moving Toward an Era Where Data Improves “Wellness”

Dr. Shinpaku

Press Room